1. Academic Validation
  2. 4R-tau isoform induction via TDP-43 in neurons in response to insulin: converging signaling pathways with implications for neurodegenerative disease

4R-tau isoform induction via TDP-43 in neurons in response to insulin: converging signaling pathways with implications for neurodegenerative disease

  • Acta Neuropathol Commun. 2025 Dec 24;13(1):258. doi: 10.1186/s40478-025-02174-x.
Carina Weissmann # 1 Libia Catalina Salinas Castellanos # 2 Mayra Micaela Montes 2 Gokhan Uruk 3 Hossam Youssef 3 R Ross Reichard 4 Rodolfo Gabriel Gatto 3 Keith A Josephs 3
Affiliations

Affiliations

  • 1 IFIBYNE-UBA-CONICET Buenos Aires, Buenos Aires, Argentina. [email protected].
  • 2 IFIBYNE-UBA-CONICET Buenos Aires, Buenos Aires, Argentina.
  • 3 Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • 4 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • # Contributed equally.
Abstract

Tau Protein isoforms, regulated during development, are influenced by the nuclear factor TDP-43, which plays a crucial role in tau mRNA stability and exon 10 inclusion. Both tau and TDP-43 are prone to pathological phosphorylation and aggregation, with specific phosphorylated forms of TDP-43 linked to cytoplasmic mislocalization and alterations in the 3R/4R tau ratio as detected in different pathologies. In this study, we show that Insulin treatment of embryonic mouse primary cortical neurons-cells that normally express only 3R-tau-induces the expression of 4R-tau, suggesting that metabolic signaling can influence tau isoform expression in a developmentally immature neuronal context. In addition, experiments in HEK293 cells revealed isoform-specific stabilization effects and showed that Insulin promotes TDP-43 redistribution to the cytoplasm along with a phosphorylation pattern. These results underscore the complex interplay between TDP-43 and tau isoforms and metabolic signaling pathways that play a crucial role in their expression and localization with potential implications for understanding mechanisms of neurodegenerative disease onset and progression.

Keywords

3R/4R tau ratio; Alzheimer´s disease; Corticobasal degeneration; Insulin; TDP-43; Tau splicing.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-15535
    98.13%, Casein Kinase Inhibitor